Country Offices
Regional HQ
Philippines
Thailand
Singapore
Malaysia & Brunei
Hong Kong & Macau
Taiwan
Korea
Vietnam & Cambodia
India
Indonesia

Bangladesh
Profile & Services
Management
Principals
Contact



Zuellig Pharma Bangladesh Limited was incorporated in June 2006 as Zuellig Pharma continued its expansion into South Asia. Establishing its Corporate Office in the Tejgaon area of Dhaka, Zuellig Pharma worked hard to establish its client base in Bangladesh and was rewarded in February 2007 with an agreement with GlaxoSmithKline Bangladesh (GSK) for the exclusive distribution of its portfolio of products through 12 branches nationally. In 2010 an exclusive distribution agreement was signed with Novartis Bangladesh for nationwide distribution of its Sandoz, Pharma and Animal Health brands.

  Our Services
  Supply chain management
  Cold chain management
  Warehousing
  Inventory management
  Primary distribution
  Secondary distribution
  Value added repackaging
  Reverse logistics
  Sales order processing
  Invoicing
  Collection
  Credit and risk management
  Sample & literature management

Zuellig Pharma Bangladesh currently distributes 40% of the multinational and 5% of the total Bangladeshi pharmaceutical market volume and has become the preferred market partner for pharmaceutical and health-care related products.

Over the past years Zuellig Pharma has invested extensively in its distribution facilities and systems. Through the 12 branches and our high quality Cold Chain storage & delivery infrastructure we store, distribute and deliver Cold Chain and regular products in a safe and timely manner to over 35,000 customers nationwide, covering all key pharmacies, hospitals, and institutions and animal health customers. Zuellig Pharma operates a system of next day delivery for its regular orders and express, same-day delivery for life-saving products.

 Bangladesh Market Fast Facts
  Population of 160MM
  2011 sales estimated at US$ 1.6Bn
  Double-digit pharma market growth expected until 2015
  100% non-reimbursable prescription market
  Exempted from TRIPS patent protection
  Predominantly a branded generic market
  245 players in the market
  97% of pharma needs are produced locally

The proprietary SDS ERP system, specifically designed for the pharmaceutical industry, provides Principals and Zuellig Pharma with instant market information.

 

 

 

Contact | Site map | Privacy | Legal disclaimer